While Elanco Animal Health Inc has overperformed by 0.52%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ELAN rose by 58.55%, with highs and lows ranging from $19.26 to $8.02, whereas the simple moving average jumped by 47.82% in the last 200 days.
On July 17, 2025, Leerink Partners Upgraded Elanco Animal Health Inc (NYSE: ELAN) to Outperform. A report published by William Blair on June 26, 2025, Upgraded its rating to ‘Outperform’ for ELAN. UBS also rated ELAN shares as ‘Buy’, setting a target price of $18 on the company’s shares in an initiating report dated December 09, 2024. Leerink Partners Initiated an Market Perform rating on December 02, 2024, and assigned a price target of $14. Morgan Stanley September 19, 2024d its ‘Overweight’ rating to ‘Equal-Weight’ for ELAN, as published in its report on September 19, 2024. Stifel’s report from January 05, 2024 suggests a price prediction of $20 for ELAN shares, giving the stock a ‘Buy’ rating. Jefferies also rated the stock as ‘Buy’.
Analysis of Elanco Animal Health Inc (ELAN)
Further, the quarter-over-quarter increase in sales is 4.81%, showing a positive trend in the upcoming months.
Elanco Animal Health Inc’s future performance can be determined with the help of several well-rounded types of analysis and research techniques, with equity being one of the most influential. The goal here is to ensure that your current return on equity of 6.83% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.40, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
The average volume for any stock is also a very valuable indicator of volatility, and ELAN has an average volume of 7.02M. On a monthly basis, the volatility of the stock is set at 2.82%, whereas on a weekly basis, it is put at 2.98%, with a gain of 3.62% over the past seven days. Furthermore, long-term investors anticipate a median target price of $18.64, showing decline from the present price of $19.2, which can serve as yet another indication of whether ELAN is worth investing in or should be passed over.
How Do You Analyze Elanco Animal Health Inc Shares?
Drug Manufacturers – Specialty & Generic giant Elanco Animal Health Inc (ELAN) is based in the USA and is one of the largest companies in the market. When comparing Elanco Animal Health Inc shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 22.00, there is a growth in quarterly earnings of 121.94%.
In addition to analyzing the fundamentals, it is also important to look at how many company employees own stock. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.95%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 108.97% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
